Post by Alexion Pharmaceuticals, Inc.

We’re excited to be in Prague for the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), where we’ll present our latest research in hypophosphatasia (#HPP) and hypoparathyroidism (#HypoPT). We look forward to engaging with experts in bone, joint and muscle health from across the globe to deepen understanding of these rare diseases and share scientific insights that could help advance patient care.